Plasma tissue inhibitor of matrix metalloproteinase-1 level is increased in normotensive non-dippers in association with impaired glucose metabolism

Hypertension Research

Volumn 31, Issue 11, 2008, Pages 2045-2051

  Ishikawa, Joji ^a,b   Hoshide, Satoshi ^a   Eguchi, Kazuo ^a   Ishikawa, Shizukiyo ^a   Pickering, Thomas G ^b   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE VARIABILITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; SLEEP WAKING CYCLE; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR FIBROSIS; AGED; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SLEEP; URINE;

ADULT; AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; SLEEP; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 58849099044     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.2045     Document Type: Article

References (28)

1. Sega R, Facchetti R, Bombelli M, et al: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777-1783.
2. O'Brien E, Sheridan J, O'Malley K: Dippers and non-dippers. Lancet 1988; 2: 397.
3. Hoshide S, Kario K, Hoshide Y, et al: Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003; 16: 434-438.
4. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T: Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875-878.
5. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23-29.
6. Lurbe E, Redon J, Kesani A, et al: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797-805.
7. Staessen JA, Thijs L, Fagard R, et al, for the Systolic Hypertension in Europe Trial Investigators: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-546.
8. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K: Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857.
9. Ohkubo T, Hozawa A, Yamaguchi J, et al: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens 2002; 20: 2183-2189.
10. Opie L, Commerford P, Gersh B, Pfeffer M: Controversies in ventricular remodelling. Lancet 2006; 367: 356-367.
11. Weber KT: Monitoring vascular sclerosis iA hypertension: a new window of opportunity. Circulation 1998; 98: 498-500.
12. Ishikawa, J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995-1001.
13. Laviades C, Varo N, Fernandez J, et al: Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98: 535-540.
14. Zureik M, Beaudeux JL, Courbon D, Benetos A, Ducimetiere P: Serum tissue inhibitors of metalloproteinases I (TIMP- 1) and carotid atherosclerosis and aortic arterial stiffness. J Hypertens 2005; 23: 2263-2268.
15. Sachdeva A, Weder AB: Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006;48 527-533.
16. Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M: Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension 2008; 51: 891-898.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
18. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
19. Okin PM, Devereux RB, Gerdts E, et al, for the LIFE Study Investigators: Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypenrophy and the prediction of outcome during antihypertensive therapy: The Losartan Intervention for Endpoint (LIFE) reduction in hypertension study. Circulation 2006; 113: 1588-1596.
20. Bella JN, Devereux RB, Roman MJ, et al: Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001; 87: 1260-1265.
21. Asbun J, Villarreal FJ: The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47 693-700.
22. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K: Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens 2005; 18: 23-29.
23. Eguchi K, Ishikawa J, Hoshide S, et al: Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects. Am Heart J 2007; 154: 79.e9-79.e15.
24. Dollery CM, McEwan JR, Henney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-868.
25. Pistrosch F, Reissmannb E, Wildbrettb J, Koehlerc C, Hanefeld M: Relationship between diumal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am J Hypertens 2007; 20: 541-545.
26. Kuroda S, Uzu T, Fujii T, et al: Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension. J Hum Hypertens 1999; 13: 257-262.
27. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G: Sodium restriction shifts cireadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859-1862.
28. Uzu T, Takeji M, Yamauchi A, Kimura G: Circadian rhythm and postural change in natriuresis in non-dipper type of essential hypertension. J Hum Hypertens 2001; 15: 323-327.